9-132897613-G-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_000368.5(TSC1):​c.2626-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,253,948 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00029 ( 0 hom., cov: 14)
Exomes 𝑓: 0.00017 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

TSC1
NM_000368.5 splice_region, intron

Scores

2
Splicing: ADA: 0.004452
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.387

Publications

2 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000368.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
NM_000368.5
MANE Select
c.2626-3C>A
splice_region intron
N/ANP_000359.1
TSC1
NM_001406592.1
c.2626-3C>A
splice_region intron
N/ANP_001393521.1
TSC1
NM_001406593.1
c.2626-3C>A
splice_region intron
N/ANP_001393522.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC1
ENST00000298552.9
TSL:1 MANE Select
c.2626-3C>A
splice_region intron
N/AENSP00000298552.3
TSC1
ENST00000490179.4
TSL:3
c.2626-3C>A
splice_region intron
N/AENSP00000495533.2
TSC1
ENST00000643875.1
c.2626-3C>A
splice_region intron
N/AENSP00000495158.1

Frequencies

GnomAD3 genomes
AF:
0.000298
AC:
31
AN:
104136
Hom.:
0
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.000664
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000202
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00215
Gnomad SAS
AF:
0.000669
Gnomad FIN
AF:
0.000276
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000367
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000172
AC:
216
AN:
1253948
Hom.:
0
Cov.:
27
AF XY:
0.000164
AC XY:
102
AN XY:
623244
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000567
AC:
16
AN:
28210
American (AMR)
AF:
0.000110
AC:
3
AN:
27254
Ashkenazi Jewish (ASJ)
AF:
0.000445
AC:
9
AN:
20218
East Asian (EAS)
AF:
0.000423
AC:
15
AN:
35452
South Asian (SAS)
AF:
0.00
AC:
0
AN:
65666
European-Finnish (FIN)
AF:
0.000634
AC:
21
AN:
33148
Middle Eastern (MID)
AF:
0.000438
AC:
2
AN:
4564
European-Non Finnish (NFE)
AF:
0.000137
AC:
135
AN:
987674
Other (OTH)
AF:
0.000290
AC:
15
AN:
51762
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.301
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000288
AC:
30
AN:
104136
Hom.:
0
Cov.:
14
AF XY:
0.000226
AC XY:
11
AN XY:
48598
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000622
AC:
15
AN:
24132
American (AMR)
AF:
0.000202
AC:
2
AN:
9924
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2992
East Asian (EAS)
AF:
0.00216
AC:
8
AN:
3710
South Asian (SAS)
AF:
0.000672
AC:
2
AN:
2974
European-Finnish (FIN)
AF:
0.000276
AC:
1
AN:
3618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
200
European-Non Finnish (NFE)
AF:
0.0000367
AC:
2
AN:
54476
Other (OTH)
AF:
0.00
AC:
0
AN:
1386
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.277
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Mar 16, 2022
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.5
DANN
Benign
0.50
PhyloP100
-0.39

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0045
dbscSNV1_RF
Benign
0.25
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060503192; hg19: chr9-135773000; API